Profile

	CNTG	DHR-PB	TMO	DHR	IDXX	A
Company Name	Centogene N.V.	Danaher Corporation	Thermo Fisher Scientific Inc.	Danaher Corporation	IDEXX Laboratories, Inc.	Agilent Technologies, Inc.
Sector	Healthcare	Healthcare	Healthcare	Healthcare	Healthcare	Healthcare
Industry	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research	Medical - Diagnostics & Research
Market Cap	$9.43M	$916.76B	$155.57B	$143.61B	$43.64B	$33.26B
Employees	0.38K	79.00K	125.00K	61.00K	11.00K	17.90K
CEO	Kim Stratton	Rainer M. Blair	Marc N. Casper	Mr. Rainer M. Blair	Jonathan J. Mazelsky	Mr. Padraig McDonnell

Ratings

	CNTG	DHR-PB	TMO	DHR	IDXX	A
Quant Rating Score	1	5	3	3	3	3
Quant Rating	Strong Sell	Strong Buy	Neutral	Neutral	Neutral	Neutral

Trading

	CNTG	DHR-PB	TMO	DHR	IDXX	A
Last Close	$0.325	$1261.26	$421.47	$201.1	$542.65	$120.45
High 52	$0.54	$1261.26	$624.21	$280.76	$542.93	$152.6
Low 52	$0.29	$1261.26	$390.2	$174.64	$361.04	$99.29
Price vs. 52 Week High	-39.81 %	0 %	-32.48 %	-28.37 %	-0.05 %	-21.07 %
Price vs. 52 Week Low	12.07 %	0 %	8.01 %	15.15 %	50.3 %	21.31 %

Total Return

	CNTG	TMO	DHR	IDXX	A
1 Month Return	0 %	6.31 %	6.27 %	5.41 %	8.46 %
3 Month Return	0 %	-13.82 %	-1.98 %	27.31 %	3.85 %
6 Month Return	0 %	-20.78 %	-14.37 %	30.59 %	-11.23 %
9 Month Return	0 %	-31.21 %	-26.58 %	11.66 %	-17.8 %
YTD Return	0 %	-18.98 %	-12.39 %	31.25 %	-10.34 %
1 Year Return	-20.73 %	-21.06 %	-16.35 %	13.71 %	-4.24 %
3 Year Return	0 %	0 %	0 %	0 %	0 %
5 Year Return	0 %	0 %	0 %	0 %	0 %

Dividends

	CNTG	DHR-PB	TMO	DHR	IDXX	A
Dividend Yield Percentage (TTM)	-	0.59 %	0.4 %	0.56 %	-	0.83 %
Dividend Paid and Capex Coverage Ration (TTM)	-13.93 %	2.93 %	4.05 %	2.93 %	7.41 %	3.43 %
Dividend Per Share (TTM)	-	1.18 %	1.64 %	1.13 %	-	0.97 %
Payout Ratio (TTM)	-	20.85 %	9.16 %	20.85 %	-	23.76 %

Growth

	CNTG	DHR-PB	TMO
Asset Growth	-16.87 %	-8.22 %	10.06 %
Gross Profit Growth	-13.4 %	1.23 %	2.02 %
Revenue Growth	2.24 %	-0.06 %	-4.73 %
Revenue 3 Year	-6.29 %	-20.76 %	8 %
Revenue 5 Year	-39.91 %	30.38 %	36.52 %
Revenue 10 Year	-98.67 %	15.17 %	7.08 %
EBIT Growth	22.79 %	-7.62 %	12.76 %
Net Income Growth	-11.59 %	-18.16 %	3.95 %
Net Income 3 Yeari Growth Per Share	-23.4 %	-40.75 %	11.67 %
Net Income 5 Yeari Growth Per Share	-57.04 %	26.78 %	30.32 %
Net Income 10 Yeari Growth Per Share	94.96 %	44.14 %	197.81 %
Operating Income Growth	19.35 %	-6.52 %	10.22 %
Operating Cash Flow Growth (CFG)	-19.86 %	-6.64 %	-1.19 %
Operating 3 Year CFG	-378.57 %	-21.78 %	23.6 %
Operating 5 Year CFG	-247.61 %	65.54 %	85.69 %
Operating 10 Year CFG	-117.36 %	70.94 %	182 %
EPS Growth	-14.41 %	-17.24 %	5.21 %
EPS Diluted Growth	-13.51 %	-17.08 %	5.73 %
Book Value Per Share	-424.77 %	-6.67 %	2.3 %
Share Holder 3 Year Equity Growth Per Share	-128.95 %	7.23 %	14.73 %
Share Holder 5 Year Equity Growth Per Share	-146.44 %	60.08 %	34.5 %
Share Holder 10 Year Equity Growth Per Share	-106.4 %	103.57 %	27.76 %
Dividend Per Share Growth	-	-5.75 %	4.82 %
Dividend 3 Year Growth Per Share	-	1.18 %	21.71 %
Dividend 5 Year Growth Per Share	-	42.62 %	44.02 %
Dividend 10 Year Growth Per Share	-	224 %	78.77 %
Debt Growth	33.74 %	-18.07 %	23.95 %
Free Cash Flow Growth	-19.05 %	-8.39 %	-6.85 %
Updated On	31 Dec 2023	31 Dec 2024	31 Oct 2024

Profitability

	CNTG	DHR-PB	TMO	DHR	IDXX	A
Gross Profit Margin TTM	35.54 %	59.74 %	41.57 %	59.74 %	61.32 %	53.79 %
Return on Assets TTM	-46.05 %	4.76 %	6.58 %	4.76 %	27.85 %	9.59 %
Return on Equity TTM	397.65 %	7.47 %	13.34 %	7.47 %	57.35 %	19.46 %
Return on Capital Employed TTM	-87.78 %	6.66 %	8.53 %	6.66 %	55.24 %	13.97 %
Net Income Per EBT TTM	100.81 %	83.59 %	92.18 %	83.59 %	79.59 %	85.05 %
EBT Per Ebit TTM	118.83 %	93.35 %	96.45 %	93.35 %	97.98 %	96.75 %
EBIT Per Revenue TTM	-61.11 %	20.26 %	17.08 %	20.26 %	29.19 %	21.38 %
Cash Flow To Debt Ratio TTM	-39.49 %	37.92 %	23.81 %	37.92 %	91.41 %	45.35 %
Receivables Turnover TTM	2.5	6.79	5.07	6.79	6.51	4.85
Payables Turnover TTM	5.56	5.57	-	5.57	12.66	5.94
Inventory Turnover TTM	12.7	3.79	4.8	3.79	3.84	3.1
Fixed Asset Turnover TTM	251.78 %	466.14 %	459.74 %	466.14 %	471.66 %	346.65 %
Asset Turnover TTM	62.91 %	30.11 %	43.31 %	30.11 %	122.35 %	54.52 %
Operating Cash Flow Per Share TTM	-1.13	8.72	21.53	8.72	11.91	5.56
Free Cash Flow Per Share TTM	-1.21	6.84	17.79	6.84	10.3	4.91
Cash Per Share TTM	64.53 %	278.24 %	1573.28 %	278.24 %	201.64 %	521.4 %
Operating Cash Flow Sales Ratio TTM	-65.41 %	26.23 %	18.97 %	26.23 %	24.63 %	23.91 %
Free Cash Flow Operating Cash Flow Ratio TTM	107.18 %	78.46 %	82.61 %	78.46 %	86.51 %	88.33 %
Cash Flow Coverage Ratios TTM	-39.49 %	37.92 %	23.81 %	37.92 %	91.41 %	45.35 %
Price To Free Cash Flows Ratio TTM	-0.24	29.02	23.14	29.3	52.1	23.76
Price To Operating Cash Flows Ratio TTM	-0.25	22.79	19.14	23.01	45.57	21.05
Price Cash Flow Ratio TTM	-0.25	22.79	19.14	23.01	45.57	21.05

Income Statement (TTM)

	CNTG	DHR-PB	TMO	DHR	IDXX	A
Revenue	$0.05B	$23.88B	$42.88B	$23.88B	$3.9B	$6.51B
Gross Profit	$0.02B	$14.21B	$17.7B	$14.21B	$2.38B	$3.54B
Gross Profit Ratio	35.54%	59.5%	41.28%	59.5%	61.04%	54.3%
EBITDA	$-0.02B	$7.28B	$11.8B	$7.28B	$1.28B	$1.87B
Net Income	$-0.04B	$3.9B	$6.34B	$3.9B	$0.89B	$1.29B
EPS Diluted	-1.26	5.29	16.53	5.29	10.67	4.43

Balance Sheet (MRQ)

	CNTG	DHR-PB	TMO	DHR	IDXX	A
Long Term Debt	$0.05B	$15.5B	$29.06B	$15.5B	$0.55B	$3.35B
Total Liabilities	$0.1B	$27.99B	$47.65B	$27.99B	$1.7B	$5.95B
Total Equity	$-0.03B	$49.55B	$49.67B	$49.55B	$1.6B	$5.9B
Total Investments	$0B	$0B	$1.56B	$0B	$0.06B	$0.18B
Total Debt	$0.08B	$16.01B	$31.28B	$16.01B	$0.99B	$3.39B
Total Assets	$0.08B	$77.54B	$97.32B	$77.54B	$3.29B	$11.85B

Cash Flow Statement (TTM)

	CNTG	DHR-PB	TMO	DHR	IDXX	A
Net Income	$-0.04B	$3.9B	$6.34B	$3.9B	$0.89B	$1.29B
Inventory	$-0B	$0.15B	$0B	$0.15B	$-0.03B	$0.03B
Dividends Paid	$0B	$-0.77B	$-0.58B	$-0.77B	$0B	$-0.27B
Operating Cash Flow	$-0.03B	$6.69B	$8.67B	$6.69B	$0.93B	$1.75B
Capital Expenditure	$-0B	$-1.39B	$-1.4B	$-1.39B	$-0.13B	$-0.38B

Related Stocks

Ticker	Name	Price
A	Agilent Technologies, Inc.	120.45
ACRS	Aclaris Therapeutics, Inc.	1.41
ADVB	Advanced Biomed Inc. Common Stock	0.724
AKU	Akumin Inc.	0.2887
APDN	Applied DNA Sciences, Inc.	4.56
AWH	Aspira Women's Health Inc.	0.082
BDSX	Biodesix, Inc.	0.287
BIAF	bioAffinity Technologies, Inc.	0.2635
BIAFW	bioAffinity Technologies, Inc.	0.1392
BIOC	Biocept, Inc.	0.4349
BNGO	Bionano Genomics, Inc.	3.3
BNR	Burning Rock Biotech Limited	3.2
CDNA	CareDx, Inc	18.85
CEMI	Chembio Diagnostics, Inc.	0.455
CHEK	Check-Cap Ltd.	0.76
CO	Global Cord Blood Corporation	2.9876
CRL	Charles River Laboratories International, Inc.	154.4
CSTL	Castle Biosciences, Inc.	20.34
DGX	Quest Diagnostics Incorporated	179.33
DHR	Danaher Corporation	201.1

ETFs With Exposure to CNTG

Ticker	ETF Name	Weight Percentage	Price
PQSG	PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF	0.15	72.5283

Unlock

Fidelitey